Oncolytic immunotherapy: multiple mechanisms of oncolytic peptides to confer anticancer immunity
Oncolytic peptides are highly effective on remodeling the tumor microenvironment and potentiating the anticancer immunity through multiple mechanisms, particularly by inducing immunogenic cell death. Intriguingly, a recent study demonstrates that LTX-315, one of the most promising and extensively st...
Saved in:
Main Authors: | Xing Huang, Tingbo Liang, Tianyu Tang, Gang Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-07-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/10/7/e005065.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis
by: Meng Wang, et al.
Published: (2022-03-01) -
Oncolytic Immunotherapy: Where Are We Clinically?
by: Akseli Hemminki
Published: (2014-01-01) -
The impact of innate immune response on the efficacy of oncolytic viruses
by: Kirill N. Trachuk, et al.
Published: (2024-12-01) -
Oncolytic Virotherapy for Hematological Malignancies
by: Swarna Bais, et al.
Published: (2012-01-01) -
Unveiling the nexus: Oncolytic viruses, extracellular vesicles, and immune modulation
by: Pierre Cordelier
Published: (2025-03-01)